R H Brakenhoff - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

R H Brakenhoff

Showing results (21-30 of 63) with videos related to

Pageof 7

Sort By:

Molecular and Biochemical Parasitology|August 1, 1986

Characterization of Plasmodium falciparum sexual stage antigens and their biosynthesis in synchronised gametocyte culturesA N Vermeulen, J van Deursen, R H Brakenhoff, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 1998

Exfoliated oral cell messenger RNA: suitability for biomarker studiesI Klaassen, M P Copper, R H Brakenhoff, et al.

Cell Biophysics|January 1, 1994

Complete ablation of small squamous cell carcinoma xenografts with 186Re-labeled monoclonal antibody E48M Gerretsen, G W Visser, R H Brakenhoff, et al.

International Journal of Cancer|August 14, 1999

Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinomaN L van Hal, G A van Dongen, M Stigter-van Walsum, et al.

Molecular Pathology : MP|February 24, 2001

Microarray techniques in pathology: tool or toy?A M Snijders, G A Meijer, R H Brakenhoff, et al.

International Journal of Cancer|June 25, 1998

Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancerF B van Gog, R H Brakenhoff, M Stigter-van Walsum, et al.

Cancer Immunology, Immunotherapy : CII|March 1, 1995

Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancerR H Brakenhoff, F B van Gog, J E Looney, et al.

Experimental Eye Research|April 1, 1992

A device for quantitative measurement of the opacity of small animal lenses: application to Xenopus laevisR H Brakenhoff, G S Elliott, F H Schut, et al.

Blood|June 25, 1998

Construction and characterization of a fusion protein of single-chain anti-CD20 antibody and human beta-glucuronidase for antibody-directed enzyme prodrug therapyH J Haisma, M F Sernee, E Hooijberg, et al.

Cancer Immunology, Immunotherapy : CII|December 9, 1997

Sequence variation in the monoclonal-antibody-U36-defined CD44v6 epitopeN L Van Hal, G A Van Dongen, C B Ten Brink, et al.

Pageof 7

Search research articles

Showing results (21-30 of 63) with videos related to

Sort By:

Pageof 7

Molecular and Biochemical Parasitology|August 1, 1986

Characterization of Plasmodium falciparum sexual stage antigens and their biosynthesis in synchronised gametocyte culturesA N Vermeulen, J van Deursen, R H Brakenhoff, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 1998

Exfoliated oral cell messenger RNA: suitability for biomarker studiesI Klaassen, M P Copper, R H Brakenhoff, et al.

Cell Biophysics|January 1, 1994

Complete ablation of small squamous cell carcinoma xenografts with 186Re-labeled monoclonal antibody E48M Gerretsen, G W Visser, R H Brakenhoff, et al.

International Journal of Cancer|August 14, 1999

Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinomaN L van Hal, G A van Dongen, M Stigter-van Walsum, et al.

Molecular Pathology : MP|February 24, 2001

Microarray techniques in pathology: tool or toy?A M Snijders, G A Meijer, R H Brakenhoff, et al.

International Journal of Cancer|June 25, 1998

Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancerF B van Gog, R H Brakenhoff, M Stigter-van Walsum, et al.

Cancer Immunology, Immunotherapy : CII|March 1, 1995

Construction and characterization of the chimeric monoclonal antibody E48 for therapy of head and neck cancerR H Brakenhoff, F B van Gog, J E Looney, et al.

Experimental Eye Research|April 1, 1992